[Septic shock and endothelin].
Mitaka
Chieko
C
Department of Critical Care Medicine, Tokyo Medical and Dental University Graduate School.
D000818:Animals; D000077300:Bosentan; D016084:Bronchoconstriction; D002199:Capillary Permeability; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1 / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology; D010456:Peptides, Cyclic / Q000627:therapeutic use; D044022:Receptor, Endothelin A / Q000502:physiology; D044023:Receptor, Endothelin B / Q000502:physiology; D012772:Shock, Septic / Q000188:drug therapy / Q000209:etiology*; D013449:Sulfonamides / Q000627:therapeutic use; D014661:Vasoconstriction
D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1; D010456:Peptides, Cyclic; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D013449:Sulfonamides; C088196:TAK 044; D000077300:Bosentan